Last reviewed · How we verify
NCT06664281
Effects of SIT Combined with Remote Ischemic Preconditioning on Vascular Function in Young Women with Masked Obesity
NA trial testing SIT in Vascular Function in 44 participants. Completed in 30 December 2023.
30 October 2023
Quick facts
| Lead sponsor | Beijing Sport University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 44 |
| Start date | 28 February 2023 |
| Primary completion | 30 October 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- SIT
- SIT combined RIPC
Conditions studied
- Vascular Function — all drugs for Vascular Function →
Sponsor
Beijing Sport University
Who can join
Adults 18 to 30, female only, with Vascular Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison of the effects of combined Sprint Interval Training (SIT) with Remote Ischemic Preconditioning (RIPC) and SIT on vascular function in young women with masked obesity.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of sprint interval training combined with remote ischaemic preconditioning on vascular function in young women with masked obesity.
Ji Y, Yang L, Zhang P. · · 2026 · PMID 40982049 · DOI 10.1007/s00421-025-05970-4
Verify or expand the search:
- PubMed search for NCT06664281
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SIT
Trials testing the same drug.
- NCT06656780 — Stress Inoculation Training (SIT): An Evidence-Based, Military Aligned Psychological Performance and Health Sustainment · NA · not yet recruiting
- NCT06658509 — Regulation of Different IT on Vascular Function of Overweight Female University Students · NA · completed
- NCT04155827 — Gender Specific Responses of Overweight and Obese Adults to Sprint Interval Training · NA · completed
- NCT04195165 — The Effect of Sitting and Moderate Exercise on Plasma Insulin and Glucose Responses to an Oral Glucose Tolerance Test · NA · unknown
- NCT03888508 — Comparison of Efficacy of Sensory Integration Therapy in Children With Cerebral Palsy · NA · completed
Other recruiting trials for Vascular Function
Currently open trials in the same condition.
- NCT06823570 — Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension. · NA · recruiting
- NCT06128278 — Acute Equol Supplementation and Vascular Function in Women With and Without CKD · Phase 2 · recruiting
- NCT05468255 — The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults · NA · recruiting
Other Beijing Sport University trials
Trials by the same sponsor.
- NCT07591194 — The Effects of Immersive Virtual Reality-Based Exergaming Combined With Transcranial Direct Current Stimulation on Execu · NA · not yet recruiting
- NCT07360821 — Investigation of Autonomic Stress Response Patterns in College Students With Varying Physical Activity Levels · not yet recruiting
- NCT07496944 — Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue · NA · completed
- NCT07509970 — Effects of Astaxanthin Supplementation on Soccer Performance Under Fatigue · NA · completed
- NCT07264907 — Tai Chi Improves Sleep Quality in Mild to Moderate Chronic Insomnia Patients · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06664281 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Sport University
- Last refreshed: 29 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06664281.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing